QDEL חוב כולל להון QuidelOrtho Corporation

QuidelOrtho (QDEL) generates revenue by developing rapid infection diagnostic systems and clinical molecular analysis kits. This price chart for the company on GURU.Markets reflects the 1.77 indicator. A diverse range of home and laboratory tests for detecting cardiac or respiratory pathologies minimizes the impact of seasonality. The business is currently overcoming challenges following a major merger, striving to restore profitability and organic growth during the asset integration period.

This ratio determines the proportion of borrowed funds within the equity structure, measuring financial leverage and the issuer's dependence on borrowing costs. By analyzing the changing ratio of debt to equity, an investor can assess whether the stable revenues of QuidelOrtho (QDEL) from the sale of consumables for diagnostic equipment are sufficient to service the debt load without risking a decline in share value.